Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
2011

How Alphaviral Vaccines Work

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Tanja I Näslund, Linda Kostic, Eva KL Nordström, Margaret Chen, Peter Liljestöm

Primary Institution: Karolinska Institutet

Hypothesis

Are innate signaling pathways important for the immunogenicity of alphaviral replicon-based vaccines?

Conclusion

Alphaviral replicon-based vectors activate multiple innate signaling pathways that both enhance and limit the immune response.

Supporting Evidence

  • Alphaviral replicon-based vectors induce strong immune responses.
  • Type I interferon can suppress T cell responses after vaccination.
  • IRF3 is crucial for a robust immune response.

Takeaway

This study shows that certain immune signals help vaccines work better, but too much of these signals can actually make the vaccine less effective.

Methodology

Mice were immunized with DREP or VREP and immune responses were measured using ELISpot.

Limitations

The study primarily used mouse models, which may not fully represent human responses.

Participant Demographics

Female mice, 6-12 weeks old.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1743-422X-8-36

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication